Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents.
暂无分享，去创建一个
A. Scott | M. Brechbiel | M. Lackmann | A. Boyd | M. Spanevello | Sabine H. Wimmer-Kleikamp | F. Lee | C. Stylianou | C. To | V. Spirkoska | Christopher J. Vearing